DuPont Pharmaceuticals merges with BMS
Bristol-Myers Squibb has completed its $7.8 billion purchase of DuPont Pharma. The acquisition, which was announced on June 7, closed Oct. 1. DuPont Pharma is expected to promote BMS growth by providing a greater focus on its medicine business. Among the
Bristol-Myers Squibb has completed its $7.8 billion purchase of DuPont Pharma. The acquisition, which was announced on June 7, closed Oct. 1. DuPont Pharma is expected to promote BMS growth by providing a greater focus on its medicine business. Among the myriad drugs in the DuPont portfolio is the technetium-based cardiac radiopharmaceutical Cardiolite. Under the terms of the agreement, Bristol-Myers Squibb paid the $7.8 billion in cash. The transaction is expected to be accretive to earnings beginning in 2003.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 2nd 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 2nd 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
Twenty Years of CT Colonography for Colorectal Cancer Screening: What the Research Reveals
August 2nd 2025Computed tomography colonography (CTC) demonstrated a 91.6 percent positive predictive value (PPV) for polyps > 6 mm, according to new research involving over 9,000 patients who underwent CTC for primary asymptomatic colorectal cancer screening.
